 |
 |

Middle Segment PancreatectomyInvited Commentary
Keith D. Lillemoe, MD
Baltimore, Md
Arch Surg. 1998;133:331.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The perioperative results with pancreatic resection have improved dramatically during the last decade. At high-volume centers, perioperative mortality has been consistently reported to be less than 5% following pancreaticoduodenectomy. Similarly, distal pancreatectomy can be accomplished with minimal morbidity and rare mortality. Despite these improved results, a few problems remain. One such problem is that cysts and tumors arising in the midbody of the pancreas may not be optimally managed by either distal pancreatectomy or pancreaticoduodenectomy. In many cases the central location of these tumors, which are most often benign if truly candidates for resection, requires a significant extension of the resection either proximally toward the head or distally to include the tail-sacrificing normal pancreatic tissue. These extensive resections frequently result in either pancreatic exocrine or endocrine insufficiency, and with distal pancreatectomy often necessitate splenectomy.
Z'graggen et al have nicely described their technique of midpancreatic resection and . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Middle Segment Pancreatectomy: A Novel Technique for Conserving Pancreatic Tissue
Andrew L. Warshaw, David W. Rattner, Carlos Fernández-del Castillo, and Kaspar Z'graggen
Arch Surg. 1998;133(3):327-331.
ABSTRACT
| FULL TEXT
|